"","Num","POD","SD","%","Genes","KE"
"SYNTHESIS AND DEGRADATION OF KETONE BODIES","2","0.00356839566285016","0.308870935741589","33.33","acat1, hmgcs1","NOT INCREASED CIRCULATING KETONE BODIES"
"CTOME SYNTHESIS OF KETONE BODIES","2","0.00356839566285016","0.308870935741589","25","acat1, hmgcs1","DECREASED KETOGENESIS PRODUCTION OF KETONE BODIES; DECREASED KETOGENESIS"
"ABNORMAL BLOOD POTASSIUM CONCENTRATION","2","0.00865851662596864","0.0929426259429571","16.67","calm3a, nr3c2","INCREASED BLOOD POTASSIUM CONCENTRATION"
"NADPH REGENERATION","2","0.0107097182221588","0.131652664930807","40","pgam1b, tkta","INHIBITION HMG-COA REDUCTASE"
"REGULATION OF PH","2","0.0929220525187322","0.645549252464626","14.29","atp6v1ba, atp6v1h","DECREASE INTRACELLULAR PH"
"RENAL TUBULAR DYSFUNCTION","5","0.209251244906431","0.411612955952416","19.23","atp6v1ba, mt-co2, ndufb9, pex19, pmm2","INCREASE HYPERPLASIA RENAL TUBULAR CELLS; INCREASE CYTOTOXICITY RENAL TUBULAR CELL; INCREASE ADENOMAS/CARCINOMAS RENAL TUBULAR; OCCURRENCE RENAL PROXIMAL TUBULAR NECROSIS"
"GO:0042421","2","0.217009858694002","1.56353928992893","66.67","hand2, th","DECREASED SYNTHESIS OF MOLTING FLUID PROTEASES"
"BRADYCARDIA","3","0.230310811190906","0.775746825365768","50","calm3a, nppa, uqcrfs1","INCREASED ATRIOVENTRICULAR BLOCK AND BRADYCARDIA"
"GLYCOLYSIS AND GLUCONEOGENESIS","6","0.320877521696226","0.3254319775511","26.09","eno3, ldha, mdh2, pgam1b, pgam2, tpi1b","DECREASED PCK1 EXPRESSION CONTROL POINT FOR GLYCOLYSIS/GLUCONEOGENESIS PATHWAY"
"GO:0001963","2","0.335529210787068","1.69735986427281","16.67","drd1b, th","INCREASE DOPAMINERGIC ACTIVITY; DECREASED DOPAMINERGIC ACTIVITY"
"GO:0019098","2","0.335529210787068","1.69735986427281","22.22","drd1b, th","ALTERED REPRODUCTIVE BEHAVIOUR; REDUCED BROOD CARE"
"MATING BEHAVIOR","2","0.335529210787068","1.69735986427281","22.22","drd1b, th","REDUCED ABILITY TO ATTRACT SPAWNING MATES"
"REPRODUCTIVE BEHAVIOR","2","0.335529210787068","1.69735986427281","20","drd1b, th","REDUCED SPAWNING BEHAVIOR"
"MORTALITY AGING","6","0.364180344016649","0.361341419838649","23.08","dnm1l, lipf, msh6, nras, pex19, pqbp1","REDUCED FITNESS OR EVEN MORTALITY ACIDOSIS HYPOVOLEMIC SHOCK AND ORGAN DYSFUNCTION; INCREASE MORTALITY; INCREASED MORTALITY"
"GO:0006635","6","0.507757138718408","0.371316625029816","30","acadl, acat1, akt2, echs1, pparda, ppardb","DECREASED PEROXISOMAL FATTY ACID BETA OXIDATION OF FATTY ACIDS; DECREASED MITOCHONDRIAL FATTY ACID BETA OXIDATION; DECREASED MITOCHONDRIAL FATTY ACID BETA-OXIDATION; INHIBITION MITOCHONDRIAL FATTY ACID BETA-OXIDATION"
"ABNORMAL CARDIAC TEST","4","0.63149297825374","0.522451359043309","30.77","calm3a, gata4, gmppb, nppa","INCREASED CARDIAC ARRTHYMIA"
"GO:0005216","4","0.661161117739668","0.496403266234278","16.67","cacna1ba, gria3a, gria4a, grik1b","IMPAIRED ION CHANNELS"
"GO:0007059","6","0.679677739108759","0.361094633554751","13.64","fbxo5, mre11a, ndc1, nup37, ppp2r1b, riok2","INCREASED CHROMOSOME MISSEGGREGATION"
"HYPERACTIVITY","11","0.727699007895026","0.178323081928765","22","cacna1ba, cars, dhdds, fgf8a, gamt, gata4, gria4a, msh6, ntrk1, ppp2r1b, tkta","INDUCTION ATAXIA PARALYSIS OR HYPERACTIVITY; INCREASED ATAXIA PARALYSIS OR HYPERACTIVITY; N/A ATAXIA PARALYSIS OR HYPERACTIVITY"
"GLOMERULAR SCLEROSIS","3","0.765015083661184","0.825711030650744","21.43","mdh2, mt-co2, nup85","DECREASED GLOMERULAR FILTRATION"
"GO:0003824","19","1.03479727998235","0.108389558193167","29.23","acat1, alas1, atic, echs1, gcat, hmgcs1, ldha, mdh2, mtap, nfs1, pgam1b, pgam2, ppm1ab, ppm1bb, psat1, sucla2, tkta, tpi1b, uqcrc2b","DECREASED DHB4/HSD17B4; DECREASE INCORPORATION OF ACTIVE IODIDE INTO IODOTYROSINES; INHIBITION PROLYL HYDROXYLASES; INHIBITION UROD; DECREASE AKT/ENOS ACTIVITY; INHIBITION DEIODINASE 2; INHIBITION DEIODINASE 1; INHIBITION IODOTYROSINE DEIODINASE IYD; INHIBITION DEIODINASE 3; INHIBITION DUAL OXIDASE; INDUCTION UPREGULATION OF GLUCURONYLTRANSFERASE ACTIVITY"
"CYTOPLASMIC RIBOSOMAL PROTEINS","7","1.08409086640282","0.309642557666837","4.86","rpl19, rpl21, rpl22, rpl38, rpl39, rps4x, rps5","OCCURRENCE CYTOPLASMIC VACUOLIZATION PODOCYTE"
"VENTRICULAR ARRHYTHMIA","3","1.1200792776844","0.647656561159446","42.86","bmp2a, calm3a, mt-co2","OCCURRENCE CARDIAC ARRHYTHMIA"
"CTOME REGULATED NECROSIS","3","1.2103348251219","0.697298702901638","14.29","casp8, cycsb, hsp90aa1.2","INCREASE NECROSIS TERMINAL BRONCHIOLAR CELLS"
"TUBE FEEDING","4","1.48936319900106","0.571671748470069","23.53","dnm1l, fgf8a, ppp2r1b, psat1","INHIBITION FEEDING"
"GO:0004970","2","1.5280080213736","1.49620295272805","33.33","gria4a, grik1b","BINDING OF AGONIST IONOTROPIC GLUTAMATE RECEPTORS"
"GO:0007568","14","1.55237494440723","0.15357636434571","16.28","akt3a, apaf1, apex1, cdk1, eno3, fbxo5, msh6, ntrk1, pitx3, sirt1, sirt3, sod1, sod2, th","ACCELERATED AGING"
"ABNORMALITY OF THE MITOCHONDRION","9","1.6112802390839","0.208451253842459","7.14","dnm1l, echs1, fdxr, hsd17b10, mrpl12, mt-co2, ndufb9, sucla2, vcp","INJURY MITOCHONDRIA; DAMAGING MITOCHONDRIA; N/A MITOCHONDRIAL DYSFUNCTION 1"
"ABNORMALITY OF ADRENAL PHYSIOLOGY","5","1.75030558310911","0.480890897298363","5.43","gata4, lipf, nr3c2, pex19, rbm28","INCREASE RENAL PATHOLOGY DUE TO VTG DEPOSITION; DECREASED RENAL ABILITY TO DILUTE URINE; OCCURRENCE KIDNEY TOXICITY; INCREASED KIDNEY FAILURE"
"G OOCYTE MEIOSIS","9","1.8051682715894","0.237582993069639","22.5","ar, calm3a, cdk1, fbxo5, ppp2r1b, rbx1, ywhah, ywhaqa, ywhaz","REDUCED MEIOTIC PROPHASE I/METAPHASE I TRANSITION OOCYTE"
"DECREASED BODY WEIGHT","33","1.91629400757697","0.0579579281182728","14.6","acat1, bmp4, cacna1ba, cars, casp8, cyb5r3, dhdds, dnm1l, echs1, fdxr, fgf8a, gata4, gria4a, jak1, lipf, mdh2, mrpl12, msh6, mt-co2, ndufb9, nfkb1, nr3c2, orc6, pccb, pex19, pmm2, pqbp1, psat1, srsf2a, stag1b, sucla2, tpm3, uqcrfs1","DECREASED BODY WEIGHT"
"CTOME VEGFR2 MEDIATED CELL PROLIFERATION","3","1.96200185024086","0.880302961071209","50","ahcyl1, nras, src","INHIBITION VEGFR2"
"HEPATOCELLULAR CARCINOMA","3","2.01949102335021","0.786963553050702","23.08","bmp2a, casp8, msh6","FORMATION HEPATOCELLULAR AND BILE DUCT TUMORS; INCREASE ADENOMAS/CARCINOMAS HEPATOCELLULAR; TUMORIGENESIS HEPATOCELLULAR CARCINOMA"
"FAS LIGAND FASL PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS HSP REGULATION","4","2.23723164383149","0.462457512572467","15.38","apaf1, casp8, cycsb, pak2a","ACTIVATION FAS; UP REGULATION FAS"
"ELECTRON TRANSPORT CHAIN","11","2.28666753046362","0.163875102565391","16.18","akr1a1b, cdk1, ciapin1, cox7a3, cycsb, mt-co2, ndufa5, ndufb9, uqcrc2b, uqcrfs1, uqcrh","DISRUPTION MITOCHONDRIAL ELECTRON TRANSPORT CHAIN"
"GO:0003714","3","2.51124851339272","0.83730134513265","15","apex1, sirt1, srsf2a","STABILIZATION PPAR ALPHA CO-REPRESSOR"
"GO:0045333","15","2.70962334149829","0.127468648035279","20.83","cdk1, cox7a3, cycsb, hif1ab, idh3a, mdh2, mt-co2, ndufa5, ndufb9, sirt3, sucla2, uqcrc2b, uqcrfs1, uqcrh, vcp","INCREASE OXIDATIVE METABOLISM"
"REGULATION OF ATPASE ACTIVITY","3","2.80333058223906","0.817882561754146","18.75","atp1b1b, msh6, sirt1","INHIBITION CA++ ATPASE"
"GO:0003707","6","2.81235657046575","0.367931596203762","18.75","ar, esrrga, nr3c2, nr4a2a, pparda, ppardb","REDUCED MATURATION INDUCING STEROID RECEPTOR SIGNALLING OOCYTE"
"GO:0007051","4","2.81874454206373","0.575365346253015","14.81","fbxo5, ppp2r1b, rae1, vcp","DISORGANIZATION SPINDLE"
"GO:0016209","3","2.84302468989835","0.970995387275394","27.27","apoeb, sod1, sod2","OXIDATION GLUTATHIONE"
"GO:0046562","7","2.86184402254869","0.229720130247394","25.93","akr1a1b, eno3, ldha, pck2, pgam1b, pgam2, tpi1b","DECREASED GLUCOSE OXIDASE ENZYME ACTIVITY"
"GO:0048469","4","2.9974829988163","0.576776744576493","16.67","fbxo5, hif1ab, nr4a2a, ppp2r1b","INCREASED OOCYTE MATURATION"
"GO:0006281","12","3.05129884268067","0.143194273022461","14.12","apex1, cdk1, lig3, mre11a, msh6, polr2c, rbx1, rfc3, rfc5, sirt1, usp1, vcp","N/A INSUFFICIENT OR INCORRECT DNA REPAIR; INCREASED INSUFFICIENT REPAIR OR MIS-REPAIR OF PRO-MUTAGENIC DNA ADDUCTS; OVERWHELMED MITOCHONDRIAL DNA REPAIR MECHANISMS; INCREASED DNA DAMAGE-REPAIR"
"GO:0030545","8","3.0921288070964","0.162582031625943","13.56","bmp2a, bmp4, fgf3, fgf8a, fsta, inhbb, nppa, wnt3a","DESENSITIZATION NICOTINIC ACETYLCHOLINE RECEPTOR"
"ABNORMAL LIVER MORPHOLOGY","25","3.09784508113788","0.0734220231397549","21.01","acat1, akt2, apoeb, bmp2a, casp8, ctsk, dhdds, dhfr, hmgcs1, hmox1a, jak1, ldlra, lipf, lpl, ndufb9, nhp2, nras, pccb, pck2, pex19, pigs, pmm2, srsf2a, tkta, vcp","INDUCTION LIVER “DYSFUNCTIONAL” CHANGES BY CGA 330050; INFLAMMATION LIVER; N/A LIVER FIBROSIS; INCREASE RBC CONGESTION IN LIVER; INCREASE LIVER AND SPLENIC HEMOSIDEROSIS; REDUCTION VITELLOGENIN SYNTHESIS IN LIVER; INCREASE VITELLOGENIN SYNTHESIS IN LIVER; FORMATION LIVER FIBROSIS; FORMATION LIVER TUMOR"
"REGULATION OF SODIUM ION TRANSPORT","3","3.17954114490227","0.927869995175224","25","ahcyl1, atp1b1b, ywhah","INHIBITION SODIUM CHANNEL; MODULATION SODIUM CHANNEL"
"ABNORMAL NASAL MORPHOLOGY","23","3.25367325588264","0.0781075917035149","14.84","akt3a, atic, bmp2a, cars, ctsk, dhdds, eif4a3, fgf3, fgf8a, gata4, idh3a, nras, nup88, orc6, pex19, pigs, plod1a, pmm2, ppp2r1b, pqbp1, prpf6, psat1, stag1b","INCREASE SITE OF CONTACT NASAL TUMORS"
"GO:0004872","34","3.37053409559183","0.0521767793946745","14.23","ar, bmp2a, bmp4, c5ar1, csf1ra, drd1b, ephb2b, erbb2, esrrga, fgf3, fgf8a, fzd7a, gabbr1a, gabbr1b, gria3a, gria4a, grik1b, inhbb, nppa, npy2rl, nr3c2, nr4a2a, nr4a2b, ntrk1, oprd1a, paqr3a, pparda, ppardb, ptger2b, tek, trhra, valopa, vipr2, wnt3a","ACTIVATION PXR/SXR"
"GO:0044414","4","3.44798886304242","0.490015554904988","10","atp6v1ba, atp6v1h, sec61g, tuba8l4","SUPPRESSION IMMUNE SYSTEM"
"GO:0009058","3","3.47697474495575","0.614994886693354","42.86","alas1, gcat, gmppb","INCREASED TRIGLYCERIDE FORMATION; INCREASED TRIGLYCERIDE FORMATION; DECREASE TETRAHYDROBIOPTERIN; ROS FORMATION"
"REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY","5","3.54217239484764","0.33786952121918","62.5","apoeb, calm3a, dhfr, hif1ab, hsp90aa1.2","INHIBITION INDUCIBLE NITRIC OXIDE SYNTHASE BY METABOLITE CGA 265307"
"UPPER MOTOR NEURON DYSFUNCTION","34","3.6535830603567","0.0557844359314515","7.17","acat1, cacna1ba, cars, cyb5r3, cyp26c1, dhdds, dnm1l, echs1, eif2b4, fdxr, fgf8a, fth1a, gamt, gfap, gmppb, gria4a, hsd17b10, mdh2, mre11a, msh6, mt-co2, pax6b, pccb, pex19, pitx3, pqbp1, psat1, rbm28, rnaseh1, sod1, sucla2, th, tpi1b, vcp","DECREASE HISTAMINERGIC NEURON EXCITATION; OCCURRENCE CYTOPLASMIC VACUOLIZATION BILE DUCT CELL; OCCURRENCE CYTOPLASMIC VACUOLIZATION KUPFFER CELL"
"G TGF BETA SIGNALING PATHWAY","7","3.67569743161219","0.236682462787181","10.29","bmp2a, bmp4, fsta, inhbb, myca, ppp2r1b, rbx1","ACTIVATION TGF-BETA PATHWAY; UP REGULATION TGFBETA1 EXPRESSION"
"PARALYSIS","4","3.95456883818249","0.609711515482992","17.39","mdh2, sod1, tpi1b, vcp","INDUCTION SOMATIC MUSCLE PARALYSIS; INDUCTION PHARYNGEAL MUSCLE PARALYSIS"
"GO:1903008","5","3.98800664578417","0.302865855946274","38.46","cdk1, ctsk, dnm1l, hif1ab, vcp","DISRUPTION LYSOSOME"
"LYSOSOMAL TRANSPORT","2","4.29311244951853","0.287517120083534","40","ncoa4, vcp","DISTURBANCE LYSOSOMAL FUNCTION"
"POSITIVE REGULATION OF CALCIUM ION TRANSPORT","3","4.35181801201362","0.818847892311191","9.38","atp1b1b, calm3a, drd1b","INCREASE CA++ INTRACELLULAR; INCREASED INTRACELLULAR CALCIUM OVERLOAD"
"ABNORMALITY OF THE LIVER","32","4.37893244790432","0.0566587190468912","4.27","acat1, akt2, apoeb, bmp2a, casp8, ctsk, dhdds, dhfr, hmgcs1, hmox1a, hsd17b10, jak1, ldlra, lipf, lpl, msh6, myca, ndufb9, nfkb1, nhp2, nras, pccb, pck2, pex19, pigs, pmm2, srsf2a, tkta, tpi1b, trhra, uqcrfs1, vcp","INCREASED INDUCTION OF UDPGT'S IN LIVER; INCREASED LIVER STEATOSIS; INCREASED LIVER STEATOSIS; N/A HEPATOTOXICITY HEPATOPATHY INCLUDING A CONSTELLATION OF OBSERVABLE EFFECTS; INDUCTION SUSTAINED HEPATOTOXICITY"
"GO:0001775","34","4.38882380991864","0.0484866634780103","17.35","apaf1, apoeb, arpc5b, bmp4, c5ar1, casp8, cebpb, cfd, cyb5r3, dusp3a, erbb2, fth1a, fynb, hmox1a, hsp90aa1.2, ldlra, msh6, nfkb1, nppa, nras, ntrk1, pak2a, pgam1b, psmd1, psmd13, ptprb, rap1b, rpl22, sart1, sod1, src, vcp, wnt3a, ywhaz","ACTIVATION DENDRITIC CELLS"
"GO:0019932","6","4.4099602387179","0.391335934221526","9.84","apoeb, drd1b, nppa, ppp2r1b, prkaa1, ptger2b","INCREASED SECOND MESSENGER PRODUCTION"
"GO:0000003","35","4.47571328176953","0.0510511269432349","17.24","ar, bmp4, casp8, cdk1, cebpb, drd1b, E2F1, eif2b4, fbxo5, fgf8a, fsta, gamt, gata4, hif1ab, hmgcs1, inhbb, ldha, mre11a, msh6, ncoa4, ndc1, nppa, ntrk1, pafah1b3, pgam2, pparda, ppardb, ppp2r1b, psmd13, rpl39, sirt1, sod1, src, th, txn","REDUCED REPRODUCTIVE SUCCESS; REPRODUCTIVE FAILURE"
"GO:0044703","22","4.6732201520117","0.0860546846947344","18.97","ar, bmp4, cdk1, drd1b, E2F1, fbxo5, fsta, gamt, inhbb, ndc1, nppa, pafah1b3, pgam2, pparda, ppardb, ppp2r1b, rpl39, sirt1, sod1, src, th, txn","N/A REPRODUCTIVE FAILURE"
"GO:0006412","12","4.68765168451535","0.150020986118951","11.11","eif2b4, eif4e2rs1, eif6, gspt1l, mrpl12, rpl19, rpl21, rpl22, rpl38, rpl39, rps4x, rps5","ALTERED PROTEIN PRODUCTION"
"GO:0004620","2","4.75608026166524","0.603215309939467","40","hmox1a, lpl","INHIBITION PHOSPHOLIPASE A"
"ABNORMALITY OF THE ABDOMINAL ORGANS","34","4.78811818154387","0.0518967598737108","20.12","acat1, akt2, apoeb, bmp2a, casp8, ctsk, dhdds, dhfr, hmgcs1, hmox1a, hsd17b10, jak1, ldlra, lipf, lpl, mre11a, msh6, mt-co2, myca, ndufb9, nfkb1, nhp2, nras, pccb, pck2, pex19, pigs, pmm2, srsf2a, tkta, tpi1b, trhra, uqcrfs1, vcp","IMPAIRED DEVELOPMENT OF REPRODUCTIVE ORGANS"
"STEROID HORMONE MEDIATED SIGNALING PATHWAY","9","4.95085971686695","0.204591712201174","8.82","ar, bmp4, esrrga, ncoa4, nr3c2, ppardb, sirt1, src, ywhah","DECREASE STEROIDOGENIC ACUTE REGULATORY PROTEIN STAR; DECREASED HSD17B10 EXPRESSION; REDUCED MATURATION INDUCING STEROID PLASMA"
"GO:0006936","8","4.95420538020451","0.218662385329823","14.55","drd1b, gamt, gata4, hspb6, nppa, pgam2, sod1, tpm3","REDUCTION ABDOMINAL MUSCLE CONTRACTION; OVERACTIVATION MUSCLE CONTRACTION"
"GO:0007588","2","5.07801377654196","0.583101869831738","14.29","atp6v1ba, hmox1a","INCREASE BILIARY EXCRETION TH GLUCURONIDE"
"SMOOTH MUSCLE CELL PROLIFERATION","6","5.51202477830897","0.306266893703981","23.08","bmp4, ctnnbip1, ddx39b, hmox1a, ppardb, sod2","HYPERTROPHY/HYPERPLASIA SMOOTH MUSCLE"
"LOCOMOTORY BEHAVIOR","9","5.5445192801367","0.225710211535293","14.52","apoeb, drd1b, gbx1, npy2rl, nr4a2a, oprd1a, pitx3, sod1, th","REDUCED SWIMMING SPEED; REDUCED SWIMMING PERFORMANCE"
"CHOLESTASIS","6","5.69351887221969","0.324422662466782","17.14","dhfr, lipf, lpl, pex19, tpi1b, trhra","INCREASED CHOLESTASIS; CHOLESTASIS PATHOLOGY"
"GO:0030728","2","5.85169789503571","0.531241199401388","40","inhbb, sirt1","DECREASE OVULATION"
"OVULATION","2","5.85169789503571","0.531241199401388","33.33","inhbb, sirt1","DECREASE OVULATION; INTERRUPTION OVULATION"
"GO:0007612","6","5.85339052318376","0.29989837687902","25","drd1b, eif4a3, ephb2b, fynb, hif1ab, th","IMPAIRMENT LEARNING AND MEMORY"
"REGULATION OF POTASSIUM ION TRANSPORT","3","6.08720061163159","0.734829963408622","18.75","atp1b1b, drd1b, nppa","INHIBITION ETHER-A-GO-GO ERG VOLTAGE-GATED POTASSIUM CHANNEL"
"GO:0005125","3","6.20359447731109","0.224635887320494","12","bmp2a, bmp4, inhbb","ACTIVATION INFLAMMATORY CYTOKINES CHEMOKINES CYTOPROTECTIVE GENE PATHWAYS"
"SYNAPTIC TRANSMISSION GLUTAMATERGIC","4","6.23767836001378","0.548581687247799","30.77","drd1b, grik1b, npy2rl, ntrk1","REDUCED PRESYNAPTIC RELEASE OF GLUTAMATE"
"GO:0099536","17","6.3469614378922","0.104176213824175","15.32","apoeb, cacna1ba, dnm1l, drd1b, eif4a3, ephb2b, fynb, gria4a, grik1b, ntrk1, rap1b, rpl22, SLC29A1_1of2, src, th, wnt3a, ywhah","DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN; DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN"
"GO:0006629","43","6.38592999139511","0.0394601276854376","20.87","acadl, acat1, akt2, alas1, alg6, apoeb, atp6v1ba, bmp2a, crk, csnk1g2a, cyb5r3, cyp26c1, dhdds, echs1, eif6, fdxr, gk5, hacd3, hmgcs1, hsd17b10, ldlra, lipf, lpgat1, lpl, nfkb1, pafah1b3, pccb, pck2, pigs, pparda, ppardb, ppp2r1b, prkaa1, ptges, ptpn13, sirt1, sirt3, sod1, src, tek, th, vldlr, ywhah","ALTERATION LIPID METABOLISM"
"HEART DEVELOPMENT","21","6.50312119953284","0.0725561796293902","16.67","ap2b1, bmp2a, bmp4, casp8, ddx39b, eif4g2b, erbb2, fgf3, fgf8a, gata4, hand2, hif1ab, mapk11, nppa, npy2rl, ppardb, rtn4a, tbx5a, tek, th, wnt3a","ALTERED LARVAL DEVELOPMENT; IMPAIRED DEVELOPMENT"
"GO:0042311","4","6.63552656769747","0.622443133205966","26.67","apoeb, drd1b, sod1, sod2","IMPAIRED VASODILATION"
"GO:0046983","41","7.01914608072037","0.0360331594637975","20.81","acat1, apoeb, ar, arntl2, atf1, atic, bmp2a, cars, cebpb, dnm1l, E2F1, eno3, erbb2, hand2, hars, hif1ab, hmgcs1, hmox1a, hsp90aa1.2, hspb6, inhbb, lpl, nfkb1, nfs1, nr4a2a, ntrk1, nudt5, nup35, pafah1b3, plod1a, pole3, polr2c, ppp2r1b, sae1, snrpc, sod1, taf11, tkta, tpi1b, uba3, ywhah","DIMERIZATION AHR/ARNT; REDUCED DIMERIZATION ARNT/HIF1-ALPHA"
"PYRUVATE METABOLIC PROCESS","16","7.09583323238539","0.0951545713488848","28.57","eif6, eno3, hif1ab, ldha, ndc1, nup35, nup37, nup85, nup88, pck2, pgam1b, pgam2, prkaa1, rae1, sec13, tpi1b","INHIBITION 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE HPPD ENZYME"
"ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES","35","7.551293203884","0.0475556631038933","8.66","acat1, alg6, apoeb, casp8, ctsk, cyb5r3, cycsb, cyp26c1, dhfr, dnm1l, echs1, ephb2b, hand2, hmox1a, hsd17b10, jak1, lipf, mdh2, msh6, mt-co2, mtap, myca, nfkb1, nhp2, nras, ntrk1, pccb, pex19, plod1a, pmm2, src, srsf2a, tek, tpi1b, uqcrfs1","DAMAGING RED BLOOD CELLS; HEMOLYSIS"
"GO:0006898","6","7.6095042433938","0.200260969774","15.79","ap2b1, apoeb, hsp90aa1.2, ldlra, vldlr, wnt3a","REDUCTION VITELLOGENIN ACCUMULATION INTO OOCYTES AND OOCYTE GROWTH/DEVELOPMENT; INCREASED LDL UPTAKE"
"GO:0042701","7","8.06780903197666","0.215782604262569","20.59","akt2, akt3a, araf, cdk1, hsp90aa1.2, mapk11, mapk9","DECREASED PROGESTERONE FROM CORPUS LUTEUM"
"ABNORMALITY OF THE PITUITARY GLAND","7","8.36069593240877","0.236731102575247","14.58","ar, bmp4, fgf8a, gata4, msh6, pmm2, rbm28","INCREASED ADENOMAS PITUITARY"
"GO:0048813","6","8.71685100671374","0.246892620923737","46.15","dnm1l, ephb2b, fynb, pqbp1, vldlr, ywhah","ABERRANT DENDRITIC MORPHOLOGY"
"ABNORMAL CIRCULATING CHOLESTEROL CONCENTRATION","5","9.19721750059938","0.218844961368505","45.45","apoeb, ldlra, lipf, lpl, pmm2","DECREASED CHOLESTEROL; PERTURBATION OF CHOLESTEROL"
"GO:0072358","23","9.59485563157832","0.0662028758754199","20.72","akt3a, ap2b1, apoeb, bmp4, c5ar1, ephb2b, erbb2, fgf8a, foxo1b, gata4, gbx2, hand2, hif1ab, hmox1a, hspb6, jak1, ldlra, pax6b, ptprb, sirt1, sod2, tbx5a, tek","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION"
"HIF1A AND PPARG REGULATION OF GLYCOLYSIS","3","9.61951507344129","0.453368524398198","25","hif1ab, ldha, tpi1b","INCREASED HIF-1 HETERODIMER; INCREASED HIF-1 ALPHA TRANSCRIPTION; ACTIVATION HIF-1"
"OXIDATIVE DAMAGE","4","9.65429108853949","0.515432605485775","20","apaf1, c5ar1, cycsb, nfkb1","INCREASED OXIDATIVE DAMAGE"
"PEPTIDYL LYSINE MODIFICATION","17","9.96442235938766","0.0803047696194069","23.94","gnl3, gtf2b, ndc1, nup35, nup37, nup85, nup88, plod1a, pole3, prkaa1, pwp1, rae1, sae1, sirt1, sirt3, sumo2b, taf10","N/A COVALENT BINDING TO PROTEIN POSSIBLY LYSINE RESIDUE"
"DNA DAMAGE RESPONSE","9","10.2512903610535","0.196921169025085","15.52","apaf1, bbc3, casp8, cdk1, cycsb, E2F1, mre11a, myca, ywhaqa","INCREASED DNA DAMAGE-REPAIR"
"GO:0022414","5","10.3392266455231","0.384828774281945","13.89","ar, fbxo5, fsta, mre11a, msh6","INCREASED REPRODUCTIVE SUCCESS"
"GO:0019904","19","10.5083993917538","0.0829203553885257","15.45","ar, casp8, crk, ctnnbip1, dnm1l, esrrga, fynb, gng12a, hif1ab, hsp90aa1.2, pax6b, sirt1, src, th, vcp, wnt3a, ywhah, ywhaqa, ywhaz","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS"
"GO:0005488","195","10.9585570990831","0.00714950781491261","18.12","acadl, acat1, akt2, akt3a, alas1, ap2b1, apaf1, apex1, apoeb, ar, araf, arntl2, arpc5b, atf1, atp5g1, atp5g3b, atp6v1ba, bmp2a, bmp4, calm3a, cars, casp8, cdk1, cebpb, cfl1l, ciapin1, csf1ra, csnk1g2a, cstf3, ctnnbip1, cyb5r3, cyp26c1, cyp2p10, ddx39b, dhfr, dhx15, dnm1l, E2F1, ehd1b, EIF1B, eif2b4, eif4a3, eif4e2rs1, eif4g2b, eif5b, eif6, eno3, enoph1, ephb2b, erbb2, esrrga, fbxo5, fgf3, fgf8a, foxo1b, fsta, fth1a, fynb, fzd7a, gata4, gbx1, gbx2, gcat, gk5, gmppb, gng12a, gnl3, gpd1b, gpd1c, gspt1l, gtf2b, hand2, hars, hif1ab, hmox1a, hmx2, hoxb2a, hoxc5a, hsp70.1, hsp90aa1.2, htatsf1, idh3a, inhbb, jak1, jak2a, ldlra, lig3, lpl, lsm6, mapk11, mapk9, mmp11b, mmp17b, mmp24, mre11a, msh6, mt2, myca, nat10, nfkb1, nfs1, nhp2, nol6, nppa, npy2rl, nr3c2, nr4a2a, nr4a2b, nras, ntrk1, nup35, oprd1a, orc6, otpb, pak2a, pax6b, pck2, pes, pex19, pitx3, plod1a, pole3, polr2c, polr3d, pparda, ppardb, ppm1ab, ppm1bb, pqbp1, prkaa1, prps1a, psat1, psmc1a, psmc1b, ptpn13, ptprb, rab11ba, rae1, rap1b, rassf1, rbm22, rbm28, rbx1, rfc3, rfc5, rhoab, riok2, rnaseh1, rnf185, rnps1, rpl19, rpl22, rps4x, rps5, rtn4a, sae1, sf3a2, sirt1, sirt3, smx5, snrpc, snupn, sod1, sod2, sox9b, sqrdl, src, srprb, srsf2a, srsf3b, srsf6a, stag1b, sucla2, sumo2b, taf11, tbx5a, tek, th, thop1, timp2b, tkta, tmsb4x, tph1b, tpi1b, tpm3, tuba8l4, uba3, ube2d1b, ube2kb, uqcrc2b, uqcrfs1, vcp, vipr2, vldlr, wnt3a","INCREASED BINDING OF CHEMICALS TO 2U SERUM"
"GO:0009790","25","11.2979641117941","0.0559989219194658","14.79","apaf1, ar, atp6v1ba, bmp2a, bmp4, casp8, cdk1, cebpb, eif4a3, ephb2b, fgf8a, gata4, gbx2, hand2, hif1ab, hmx2, hoxb2a, hoxc5a, pax6b, rpl38, rtn4a, sod1, tbx5a, th, wnt3a","DEFECT OF EMBRYOGENESIS"
"OXIDATIVE STRESS","5","11.5485932971777","0.448425345920705","20.83","hmox1a, mt2, nfkb1, sod1, sod2","PROPAGATION OXIDATIVE STRESS; N/A OXIDATIVE STRESS; INCREASE OXIDATIVE STRESS / ACTIVATION PMK-1 P38 MAPK; INCREASED OXIDATIVE STRESS; INCREASE OXIDATIVE STRESS / ACTIVATION PMK-1 P38 MAPK; INCREASE ENERGETIC DEMANDS AND THEREFORE METABOLIC STRESS; INCREASED ENERGETIC DEMANDS AND THEREFORE METABOLIC STRESS"
"ABNORMALITY OF THE OVARY","11","12.3345001181197","0.118046891605564","19.3","akt2, bmp4, eif2b4, fgf8a, gata4, hars, mre11a, msh6, myca, pax6b, pmm2","REDUCED PROSTAGLANDINS OVARY"
"REGULATION OF WNT SIGNALING PATHWAY","15","12.390822092081","0.0950520761374901","18.99","apoeb, bmp2a, csnk1g2a, ctnnbip1, nfkb1, ppp2r1b, psma8, psmb5, psmc1b, psmd1, psmd13, rbx1, src, vcp, wnt3a","INHIBITION WNT PATHWAY"
"HUMAN THYROID STIMULATING HORMONE TSH SIGNALING PATHWAY","6","12.450159849246","0.301030568879962","5.56","apex1, E2F1, jak1, myca, rap1b, src","DECREASED TRIIODOTHYRONINE T3 IN SERUM; INCREASE THYROID-STIMULATING HORMONE TSH; DECREASED THYROXINE T4 IN SERUM; INCREASED THYROID-STIMULATING HORMONE TSH"
"GO:0046903","34","13.0904643796443","0.0378566010333036","14.72","apaf1, apoeb, arpc5b, c5ar1, cacna1ba, cfd, cyb5r3, dnm1l, drd1b, fth1a, hif1ab, hmox1a, hsp90aa1.2, inhbb, lpl, mapk11, mt-co2, nfkb1, nppa, nras, pgam1b, pparda, ppardb, psmd1, psmd13, ptprb, rap1b, sirt3, SLC29A1_1of2, sod1, src, tmsb4x, tuba8l4, vcp","SUPPRESSION VLDL SECRETION; INCREASE MUCIN PRODUCTION; INCREASED SECRETION OF LOCAL GROWTH FACTORS"
"CTOME FOXO MEDIATED TRANSCRIPTION","10","13.2381948723939","0.15523429936116","35.71","akt2, akt3a, bbc3, foxo1b, sirt1, sirt3, sod2, txn, ywhaqa, ywhaz","ACTIVATION FOXO"
"GO:0006633","8","13.3367372180622","0.183663155560952","27.59","acadl, eif6, hacd3, lpgat1, lpl, prkaa1, ptges, sirt1","SYNTHESIS DE NOVO FA; INCREASED DE NOVO FA SYNTHESIS; INCREASED DE NOVO FA SYNTHESIS"
"REGULATION OF CELL DEATH","54","13.6064855132796","0.0253820757461982","20.15","akt2, ap2b1, apaf1, apex1, apoeb, ar, araf, bbc3, bmp2a, bmp4, c5ar1, casp8, cdk1, cebpb, ciapin1, dnm1l, E2F1, fgf8a, foxo1b, fynb, gata4, hand2, hif1ab, hmox1a, hsp90aa1.2, hspb6, inhbb, ldha, mapk9, mre11a, mt-co2, mt2, myca, nfkb1, nr4a2a, ntrk1, pak2a, pitx3, ppardb, ppp2r1b, prkaa1, psmc1b, rnps1, rtn4a, sirt1, sod1, sod2, src, tek, txn, vcp, wnt3a, ywhaqa, ywhaz","N/A CELL INJURY/DEATH"
"GO:0048870","33","13.6861246547231","0.0420080450735663","16.5","akt2, akt3a, apex1, apoeb, arpc5b, bmp2a, bmp4, c5ar1, cdk1, crk, drd1b, dusp3a, erbb2, fbxo5, fgf8a, fynb, gbx2, hand2, hif1ab, hmox1a, ldha, nr4a2a, nup85, pax6b, pparda, ppardb, rtn4a, sirt1, sod2, src, tbx5a, tek, tmsb4x","INCREASED MOTILITY"
"GO:0040011","38","13.8028636484403","0.034958345064501","16.74","akt2, akt3a, apex1, apoeb, arpc5b, bmp2a, bmp4, c5ar1, cdk1, crk, drd1b, dusp3a, ephb2b, erbb2, fbxo5, fgf8a, fynb, gbx1, gbx2, hand2, hif1ab, hmox1a, ldha, nr4a2a, ntrk1, nup85, pax6b, pparda, ppardb, rtn4a, sirt1, sod2, src, tbx5a, tek, tmsb4x, vldlr, wnt3a","INCREASED LOCOMOTION; INCREASED MUSCULAR WAVES IN FOOT; DECREASED LOCOMOTION"
"GO:0004882","6","13.8766889811607","0.295060986963839","17.14","ar, casp8, cdk1, ncoa4, src, ywhah","N/A ANDROGEN RECEPTOR ANTAGONISM; AGONISM ANDROGEN RECEPTOR; DECREASED ANDROGEN RECEPTOR ACTIVITY; ACTIVATION ANDROGEN RECEPTOR"
"JNK CASCADE","4","14.0260965841269","0.48499135203376","18.18","dusp3a, hacd3, mapk9, nppa","ACTIVATION JNK"
"GO:0005102","33","14.0378202996145","0.0282254144555581","15.87","apoeb, ar, bmp2a, bmp4, casp8, cebpb, crk, dusp3a, ephb2b, erbb2, fgf3, fgf8a, fsta, fynb, gtf2b, hif1ab, inhbb, jak1, lpl, ncoa4, nppa, nr4a2a, ntrk1, oprd1a, prpf6, sirt1, src, taf10, taf11, uba3, vcp, wnt3a, ywhah","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS"
"INCREASED SUSCEPTIBILITY TO FRACTURES","10","14.2026810774933","0.0845734826530493","28.57","ctsk, fgf8a, mtap, nhp2, nras, ntrk1, srsf2a, tpm3, vcp, wnt3a","INCREASED DISEASE SUSCEPTIBILITY"
"RESPONSE TO REACTIVE OXYGEN SPECIES","17","15.2235640520252","0.0942059335795334","30.36","apex1, apoeb, crk, dhfr, foxo1b, fynb, hif1ab, hmox1a, ldha, mapk9, mt2, prkaa1, sirt1, sod1, sod2, src, txn","INCREASED REACTIVE OXYGEN SPECIES"
"ABNORMALITY OF THE BLADDER","4","15.3936628984516","0.240703798926338","7.69","nr4a2a, pax6b, plod1a, vcp","REDUCED POSTERIOR SWIM BLADDER INFLATION; REDUCED ANTERIOR SWIM BLADDER INFLATION; INCREASE URINARY BLADDER CALCULI"
"ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY","25","15.4712923548834","0.0475947056903678","17.01","apoeb, bmp2a, cacna1ba, casp8, ctsk, eif4a3, fgf8a, gata4, lipf, msh6, nfkb1, nhp2, nras, ntrk1, nup88, orc6, pax6b, plod1a, pmm2, psat1, sod1, srsf2a, tbx5a, tpm3, vcp","INCREASED RESPIRATORY DISTRESS/ARREST"
"GO:0005515","4","15.4941599210023","0.259807179188137","8.51","arntl2, hsp90aa1.2, rtn4a, tbx5a","BINDING SH-/SELEN-PROTEINS; COVALENT BINDING PROTEIN"
"GO:0006839","13","15.538005889278","0.0935702820798971","28.26","atp5f1, atp5g1, atp5g3b, casp8, E2F1, hsp90aa1.2, hspa4b, prkaa1, sae1, uqcrc2b, ywhah, ywhaqa, ywhaz","REDUCTION CHOLESTEROL TRANSPORT IN MITOCHONDRIA"
"GO:0016310","20","16.4717155912629","0.0571395528292988","16","akt2, akt3a, araf, cdk1, csf1ra, csnk1g2a, ephb2b, erbb2, fynb, gk5, jak1, jak2a, mapk11, mapk9, ntrk1, pak2a, prkaa1, riok2, src, tek","ACTIVATION SP1"
"LYMPHOCYTE APOPTOTIC PROCESS","2","17.1167574840761","0.00740319785835781","25","bmp4, hif1ab","DECREASED LYMPHOCYTES"
"GO:1903409","4","17.4527296071868","0.205051883447505","16","fynb, hsp90aa1.2, mt-co2, sod1","INCREASE ROS PRODUCTION; PRODUCTION REACTIVE OXYGEN SPECIES"
"NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA","3","17.674310144161","0.499078173468639","6.25","ctnnbip1, myca, wnt3a","INCREASE HERITABLE MUTATIONS IN OFFSPRING"
"CTOME SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R","4","17.8018881413585","0.243910560921218","30.77","akt2, fgf3, fgf8a, nras","INCREASED IGF-1 MOUSE"
"GO:0009611","20","17.8891722826265","0.055854907718848","17.86","apoeb, cdk1, crk, dhfr, ehd1b, eno3, erbb2, fynb, gata4, hif1ab, hmox1a, inhbb, ntrk1, pax6b, pparda, ppardb, sod1, src, wnt3a, ywhaz","ACCUMULATION DAMAGED MITOCHONDRIAL DNA"
"GO:0042446","4","18.0433130450601","0.200237440806548","14.29","bmp2a, fdxr, hif1ab, nfkb1","INCREASE LUTEINIZING HORMONE LH; REPRESSED EXPRESSION OF STEROIDOGENIC ENZYMES"
"GO:0045444","13","18.9530874483346","0.0707339299731401","31.71","akt2, bmp2a, cebpb, E2F1, foxo1b, inhbb, lpl, nr4a2a, pparda, ppardb, sirt1, tph1b, wnt3a","INCREASED ADIPOGENESIS"
"GO:0007269","4","19.4654405535714","0.14333234790513","16","cacna1ba, dnm1l, drd1b, rap1b","OVERACTIVATION NEURONOTRANSMITTER RELEASE"
"APOPTOSIS","6","19.5069970210336","0.276858293295082","10.71","apaf1, bbc3, casp8, cycsb, myca, nfkb1","INCREASED APOPTOSIS ADENOMAS/CARCINOMAS FOLLICULAR CELL"
"ABNORMAL LUNG MORPHOLOGY","20","20.0712231039041","0.0514206689471143","15.62","apoeb, bmp2a, cacna1ba, casp8, fgf8a, gata4, lipf, nfkb1, nhp2, nras, ntrk1, nup88, orc6, pax6b, plod1a, pmm2, psat1, srsf2a, tbx5a, tpm3","INCREASE ADENOMAS/CARCINOMAS BRONCHIOLOALVEOLAR"
"BREAST CANCER PATHWAY","11","20.5864408003602","0.0837725247877934","9.65","akt2, akt3a, araf, E2F1, erbb2, fgf3, fgf8a, mre11a, myca, nras, wnt3a","N/A BREAST CANCER"
"GO:0001816","20","21.4011621262546","0.0569710392980741","16.67","c5ar1, casp8, cebpb, gata4, hif1ab, hmox1a, inhbb, lipf, lpl, mapk11, mre11a, nfkb1, polr3d, ppm1bb, pqbp1, sirt1, sod1, src, tmsb4x, wnt3a","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION; PRODUCTION OF NERVE GROWTH FACTOR  EPITHELIAL IRRITATION; NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION"
"LIPID ACCUMULATION IN HEPATOCYTES","7","22.1605113014425","0.111380480983089","21.88","akt2, apoeb, ldlra, lipf, pck2, pmm2, vcp","INCREASE PRENEOPLASTIC FOCI HEPATOCYTES"
"REGULATION OF PROTEOLYSIS","21","22.3530591668722","0.0513934343673836","18.75","apaf1, apoeb, araf, bbc3, casp8, cycsb, fynb, mapk9, mt2, myca, pak2a, psmc1b, rbx1, rnf185, sirt1, src, sumo2b, ube2kb, vcp, wnt3a, ywhaqa","IMPAIRED PROTEOSTASIS"
"NEURODEGENERATION","4","22.749606453948","0.266291391274189","26.67","fth1a, hsd17b10, sod1, vcp","N/A NEURODEGENERATION"
"ABNORMALITY OF REPRODUCTIVE SYSTEM PHYSIOLOGY","20","22.7724566751884","0.0466269606600313","19.42","akt2, ar, bmp2a, bmp4, dhdds, dnm1l, eif2b4, fgf8a, gata4, hars, idh3a, mre11a, mt-co2, nras, pmm2, prpf6, psat1, rbm28, rps4x, tkta","N/A IMPAIRMENT OF REPRODUCTIVE CAPACITY"
"CONSTITUTIVE ANDROSTANE RECEPTOR PATHWAY","3","23.1359903566781","0.348575120808313","10","alas1, foxo1b, hsp90aa1.2","SUPPRESSION CONSTITUTIVE ANDROSTANE RECEPTOR NR1L3; ACTIVATION CONSTITUTIVE ANDROSTANE RECEPTOR"
"GO:1903009","6","23.5360977256008","0.12653675184014","17.65","psma8, psmb5, psmc1a, psmc1b, psmd1, psmd13","DECREASE GTPCH-1"
"TRIGLYCERIDE METABOLIC PROCESS","8","23.7134648683057","0.122498678209212","50","apoeb, gk5, ldlra, lipf, lpgat1, lpl, pck2, sirt1","ACCUMULATION TRIGLYCERIDE"
"ABNORMAL OVARIAN MORPHOLOGY","6","23.7282384248511","0.137331757388668","16.22","akt2, fgf8a, gata4, hars, pax6b, pmm2","PROMOTION OVARIAN GRANULAR CELL TUMORS; DECREASED OVARIAN E2; PROMOTION OVARIAN ADENOMAS"
"GO:0030163","27","23.7362380170462","0.0362844163723179","17.65","ap2b1, apoeb, araf, casp8, cdk1, ctsk, fbxo5, foxo1b, fynb, gfap, hsp90aa1.2, ldlra, mapk9, psma8, psmb5, psmc1a, psmd1, psmd13, rbx1, rnf185, sirt1, sumo2b, ube2d1b, ube2kb, usp1, vcp, vldlr","INCREASED CATABOLISM OF MUSCLE PROTEIN"
"CYANOSIS","4","25.0322427513215","0.256215720244639","21.05","cyb5r3, gata4, hsd17b10, psat1","N/A CYANOSIS OCCURS"
"NRF2 PATHWAY","5","25.255326871067","0.154856419758051","12.5","fth1a, hmox1a, hsp90aa1.2, ppardb, txn","ACTIVATION NRF2"
"DECREASED FERTILITY","3","26.0502225936573","0.432162779340724","3.95","ar, fgf8a, gata4","IMPAIRED FERTILITY; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; REDUCTION CUMULATIVE FECUNDITY AND SPAWNING; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; DECREASED TESTOSTERONE"
"GO:0042060","14","26.4054562006834","0.0583433311156468","15.91","apoeb, crk, ehd1b, eno3, erbb2, fynb, gata4, hif1ab, hmox1a, pparda, ppardb, src, wnt3a, ywhaz","FAILURE IN VASCULAR REPAIR MECHANISMS UNRESOLVED BLOOD LOSS HEMORRHAGE"
"SOMATIC MUTATION","9","27.1414307557197","0.165470674181886","10.71","ar, casp8, erbb2, foxo1b, msh6, myca, nras, pax6b, src","INCREASED INDUCED MUTATIONS IN CRITICAL GENES; INCREASE MUTATIONS; INCREASE MUTATIONS IN CRITICAL GENES"
"GO:0019882","7","28.0897675877596","0.112676828398766","11.86","ap2b1, psma8, psmb5, psmc1a, psmd1, psmd13, sec13","GENERATION OF NOVEL EPITOPES  ANTIGEN PRESENTATION"
"GO:0015631","3","29.9948289472043","0.0185635804993448","15.79","dnm1l, fynb, rae1","BINDING TUBULIN"
"POSITIVE REGULATION OF GENE EXPRESSION","40","30.8742414949318","0.0230300997303116","22.1","ar, bmp2a, bmp4, c5ar1, casp8, cebpb, ddx39b, drd1b, E2F1, eif4a3, eif4g2b, eif6, ephb2b, erbb2, fgf3, fgf8a, gata4, hand2, hif1ab, hmox1a, hmx2, hsp90aa1.2, lpl, mapk11, mapk9, mre11a, mt2, myca, nat10, nfkb1, pax6b, polr3d, pqbp1, prkaa1, rbm22, rps4x, sod1, src, wnt3a, znrd1","ALTERED GENE EXPRESSION"
"GO:0006954","19","31.9730450731995","0.0574237952214348","16.24","apoeb, bmp2a, c5ar1, cebpb, ctnnbip1, hif1ab, hmox1a, ldlra, lipf, lpl, nfkb1, nppa, pparda, ppardb, ptger2b, ptges, sod1, tek, tmsb4x","INCREASE INFLAMMATION; INCREASE INFLAMMATION CORNEAL CELLS; INFILTRATION INFLAMMATORY CELLS; INCREASED INFLAMMATION; CHRONIC COUGH RESPIRATORY IRRITABILITY"
"ENDOMETRIAL CANCER","6","32.3244850945062","0.085065247767484","8.82","akt2, akt3a, araf, erbb2, myca, nras","INCREASE ENDOMETRIAL ADENOCARCINOMAS"
"GO:0010463","4","34.4117614224958","0.124789949643891","33.33","bmp2a, bmp4, ctnnbip1, hand2","INCREASED PROLIFERATION OF MESENCHYMAL CELLS"
"GO:0050663","5","34.5443643468201","0.206237301000671","16.67","c5ar1, lpl, mapk11, src, tmsb4x","RELEASE CYTOKINE"
"IMMUNOLOGIC HYPERSENSITIVITY","5","35.8626978417945","0.198353350622371","21.74","casp8, fgf8a, jak1, ptger2b, srsf2a","INCREASE ALLERGIC RESPIRATORY HYPERSENSITIVITY RESPONSE"
"GO:0050805","3","36.3288388344318","0.111440277694241","17.65","drd1b, eif4a3, rap1b","INCREASED NEURONAL SYNAPTIC INHIBITION"
"CTOME ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA","5","36.6678728544039","0.185976341166729","45.45","akt2, akt3a, ywhah, ywhaqa, ywhaz","DIRECT MITOCHONDRIAL INHIBITION; MITOCHONDRIAL IMPAIRMENT"
"CTOME CELLULAR RESPONSE TO HYPOXIA","8","37.1174541750645","0.0643927641479029","18.6","hif1ab, psma8, psmb5, psmc1b, psmd1, psmd13, rbx1, ube2d1b","N/A HYPOXIA"
"GO:0070265","3","38.606028187992","0.162741578949247","27.27","casp8, dnm1l, mt-co2","INCREASE TISSUE DEGENERATION NECROSIS & ATROPHY; INCREASED ONCOTIC NECROSIS"
"GO:0050665","3","40.0944751830606","0.158544134521292","50","fynb, mt-co2, sod1","DECREASED HYDROGEN PEROXIDE PRODUCTION"
"GO:0051899","3","40.5718542389878","0.310759245284832","14.29","cacna1ba, src, ywhah","OCCURRENCE A PAROXYSMAL DEPOLARIZING SHIFT; PROLONGED DEPOLARIZATION OF NEURONAL MEMBRANE"
"GO:0032964","3","41.4876528406417","0.187202625322025","30","bmp4, pparda, ppardb","ACCUMULATION COLLAGEN; EXPRESSION OF COLLAGEN"
"GO:0006915","3","41.8126441215733","0.149512991449034","9.68","apaf1, casp8, ciapin1","CHANGES/INHIBITION CELLULAR HOMEOSTASIS AND APOPTOSIS; DECREASED APOPTOSIS EPITHELIAL CELLS; INCREASED APOPTOSIS DECREASED LEYDIG CELLS"
"GO:0001935","9","42.3395873128931","0.0512685453979572","25","akt3a, apoeb, bmp2a, bmp4, hif1ab, hmox1a, nras, sirt1, tek","INCREASED PROLIFERATION ENDOTHELIAL CELLS"
"HEMOGLOBIN METABOLIC PROCESS","2","42.744930184014","0.273645665743679","33.33","alas1, hif1ab","ALTERED REGULATION ALPHA HEMOGLOBIN"
"PERICARDIAL EFFUSION","2","42.832816398107","0.287028875913865","50","pmm2, uqcrfs1","INCREASE PERICARDIAL EDEMA"
"GO:0006636","2","45.8496804239666","0.100950741036272","16.67","ptges, sirt1","UP REGULATION UNSATURATED FATTY ACID"
"GO:0050673","20","46.4860475464608","0.0338404568140908","24.39","akt3a, apoeb, ar, bmp2a, bmp4, c5ar1, cebpb, erbb2, fsta, hif1ab, hmox1a, nras, pax6b, pparda, ppardb, rtn4a, sirt1, tek, wnt3a, ywhaqa","INCREASE REGENERATIVE CELL PROLIFERATION TUBULAR EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION TERMINAL BRONCHIOLAR EPITHELIAL CELLS"
"NUCLEAR RECEPTORS","3","50.3148234123621","0.173158977023156","5.77","ar, nr4a2a, ppardb","ACTIVATION HEPATIC NUCLEAR RECEPTORS"
"BLADDER CANCER","7","52.7577072878894","0.0829227271401501","16.67","araf, E2F1, erbb2, myca, nras, rassf1, src","INCREASE CANCER"
"G VEGF SIGNALING PATHWAY","5","53.3424179220199","0.0965388001156118","23.81","akt2, akt3a, mapk11, nras, src","REDUCED PRODUCTION VEGF"
"PROGRESSIVE HEARING IMPAIRMENT","2","54.9509614166722","0.379869642522628","25","fgf3, mt-co2","REDUCED HEARING; REDUCED HEARING"
"G JAK STAT SIGNALING PATHWAY","4","55.4691360960595","0.11270766452258","25","akt2, akt3a, jak1, myca","ACTIVATION JAK/STAT PATHWAY"
"MALE REPRODUCTIVE SYSTEM NEOPLASM","4","58.4302222524396","0.117215880555455","26.67","ar, ephb2b, gata4, mre11a","MALFORMATION MALE REPRODUCTIVE TRACT; INDUCTION MALE REPRODUCTIVE TRACT; MALFORMED MALE REPRODUCTIVE TRACT"
"GO:0043542","8","59.1040227679029","0.0550813093976388","22.86","akt3a, apoeb, bmp4, hif1ab, hmox1a, sirt1, tek, tmsb4x","INCREASED MIGRATION ENDOTHELIAL CELLS"
"CTOME METABOLISM OF PORPHYRINS","2","59.4430706387189","0.172376220076269","66.67","alas1, hmox1a","ACCUMULATION HIGHLY CARBOXYLATED PORPHYRINS"
"CTOME SIGNALING BY EGFR","2","62.2876862279721","0.323315601748512","25","nras, src","ACTIVATION EGFR"
"GO:0060291","3","63.8795182682323","0.136962147925599","21.43","apoeb, drd1b, ephb2b","DECREASED LONG-TERM POTENTIATION LTP"
"GO:0015908","4","64.3078604023597","0.114548313269741","18.18","akt2, apoeb, pparda, ppardb","INCREASED FA INFLUX"
"SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR","3","66.7650169244026","0.167525136568566","8.82","crk, rap1b, src","OCCURRENCE CYTOPLASMIC VACUOLIZATION HEPATOCYTE; OCCURRENCE BALLOONING DEGENERATION HEPATOCYTE"
"ABNORMAL NEURON MORPHOLOGY","4","68.3762112313348","0.132857305737768","25","rbm28, sod1, tuba8l4, vcp","HYPERPOLARISATION NEURON"
"ABNORMAL CORNEAL EPITHELIUM MORPHOLOGY","2","70.9435898956435","0.316144378787659","15.38","ntrk1, pax6b","INCREASED ACCUMULATION OF ALPHA2U MICROGLOBULIN PROXIMAL TUBULAR EPITHELIUM"
"GO:0007249","7","74.8739762607757","0.0502533237783158","16.28","casp8, fynb, hacd3, hmox1a, nfkb1, ppm1bb, sirt1","INHIBITION NUCLEAR FACTOR KAPPA B NF-KB"
"GO:0030331","2","76.637587974609","0.259647969479552","22.22","src, taf10","INCREASED ER BINDING TO DNA CLASSICAL PATHWAY; INCREASED ER BINDING TO TF TO DNA NON-CLASSICAL PATHWAY"
"LUNG FIBROSIS","3","81.6965146445322","0.123004785141312","8.33","cebpb, hmox1a, mt2","LUNG FIBROSIS"
"GO:0030154","7","82.5994042719917","0.0599832290013299","10.77","fgf3, fsta, fynb, otpb, pparda, ppardb, src","DIFFERENTIATION OF MYOFIBROBLAST"
"LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS","3","85.0458519430277","0.153526466089717","50","ap2b1, apoeb, vldlr","UP REGULATION LDLR LOW DENSITY LIPOPROTEIN RECEPTOR"
"RESPONSE TO NITRIC OXIDE","4","90.0180715392177","0.0600375404092911","57.14","crk, foxo1b, mt2, txn","DECREASED NITRIC OXIDE"
"GO:0010468","3","91.4535320071316","0.181637686420325","18.75","mapk11, mapk9, pax6b","DECREASED TRANSCRIPTION OF GENES BY AR"
"GO:0007009","3","91.8462040157679","0.148023557722295","33.33","akt2, ar, sod1","NARCOSIS"
"LIPID METABOLISM PATHWAY","3","94.9541962677293","0.149527524429046","25","akt2, akt3a, prkaa1","DAMAGE LIPID BILAYER"
"GO:1904019","3","103.614507631236","0.140047348676581","13.64","E2F1, hmox1a, tek","DECREASE APOPTOSIS OF CILIATED EPITHELIAL CELLS"
"GO:0019226","2","106.540620873777","0.071669195110704","16.67","drd1b, sod1","REDUCTION ECDYSIS MOTONEURON BURSTS"
"CTOME ACTIVATION OF AMPK DOWNSTREAM OF NMDARS","2","136.619058583252","0.0586873048279752","15.38","prkaa1, tuba8l4","INHIBITION NMDARS; OVERACTIVATION NMDARS"
"GO:0030520","2","188.80112717578","0.0172287099177579","25","ar, src","ACTIVATION ESTROGEN RECEPTOR ALPHA"
